Secaucus
-
Quest Expands in Cancer Testing With $300M Haystack Oncology Acquisition
Quest Diagnostics is acquiring liquid biopsy company Haystack Oncology. The startup’s technology is used for identifying cancer patients who need adjuvant therapy.
-
Quest Diagnostics to start coronavirus testing Monday
The lab testing company made the announcement as the virus has rapidly spread across the world, and the administration’s response has received widespread criticism. LabCorp also announced the availability of its test.
-
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.